source
- Ultragenyx to cut 20% of staff and halve R&D budget as it pivots to commercial salesUltragenyx announced it will reduce its workforce by about 20%, bringing headcount down to roughly 1,000 employees. The cuts follow an earlier 10% reduction announced in February and are part of a…
- Charles River partners with Ipsen to employ virtual control groups in toxicology studiesCharles River Laboratories and French biopharma Ipsen announced a collaboration to use Charles River’s virtual control group (VCG) database in an upcoming toxicology study. The VCG approach aims t…